Dr Michael Head

Experts / Dr Michael Head

Senior Research Fellow in Global Health, University of Southampton

Dr Michael Head is a Senior Research Fellow in Global Health, based in the Clinical Informatics Research Unit at the University of Southampton, UK. He has a background in public health research and infectious disease epidemiology, with research links in Ghana, Togo, Ethiopia and Brazil. His main research interests are pneumonia and also Neglected Tropical Diseases, including scabies and onchocerciasis. Michael also analyses portfolios of research, to review levels of funding for different diseases and to provide insight into research strength, knowledge gaps, and future priorities. He has communicated extensively with the written and TV media throughout the COVID-19 pandemic.

AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation

The development has been covered in various media outlets as primarily related to the known “adverse events”, namely the small risk of blood clots. However, other factors are far more likely to be driving this decision...

Art of medicine

Clinical Articles

Billions is spent on cancer research globally – but is it money well spent?

In 2020, 19 million people around the world received a cancer diagnosis. By 2040, that number is expected to reach 28 million. Poorer countries will be especially hard hit, with an increasing number of cases and more deaths, compared with richer countries.

Billions is spent on cancer research globally – but is it money well spent?

In 2020, 19 million people around the world received a cancer diagnosis. By 2040, that number is expected to reach 28 million. Poorer countries will be especially hard hit, with an increasing number of cases and more deaths, compared with richer countries.

By Dr Michael Head, Prof Ramsey Cutress, Stuart McIntosh

Clinical Articles

Art of medicine

AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation

The development has been covered in various media outlets as primarily related to the known “adverse events”, namely the small risk of blood clots. However, other factors are far more likely to be driving this decision...

By Dr Michael Head

Clinical Articles

Infectious diseases, Public health

Dr Michael Head

Senior Research Fellow in Global Health, University of Southampton

More from this expert

AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation

The development has been covered in various media outlets as primarily related to the known “adverse events”, namely the small risk of blood clots. However, other factors are far more likely to be driving this decision...

Billions is spent on cancer research globally – but is it money well spent?

In 2020, 19 million people around the world received a cancer diagnosis. By 2040, that number is expected to reach 28 million. Poorer countries will be especially hard hit, with an increasing number of cases and more deaths, compared with richer countries.

Billions is spent on cancer research globally – but is it money well spent?

In 2020, 19 million people around the world received a cancer diagnosis. By 2040, that number is expected to reach 28 million. Poorer countries will be especially hard hit, with an increasing number of cases and more deaths, compared with richer countries.

AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation

The development has been covered in various media outlets as primarily related to the known “adverse events”, namely the small risk of blood clots. However, other factors are far more likely to be driving this decision...

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.

Dr Michael Head

Senior Research Fellow in Global Health, University of Southampton

More from this expert

AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation

The development has been covered in various media outlets as primarily related to the known “adverse events”, namely the small risk of blood clots. However, other factors are far more likely to be driving this decision...

Billions is spent on cancer research globally – but is it money well spent?

In 2020, 19 million people around the world received a cancer diagnosis. By 2040, that number is expected to reach 28 million. Poorer countries will be especially hard hit, with an increasing number of cases and more deaths, compared with richer countries.

Billions is spent on cancer research globally – but is it money well spent?

In 2020, 19 million people around the world received a cancer diagnosis. By 2040, that number is expected to reach 28 million. Poorer countries will be especially hard hit, with an increasing number of cases and more deaths, compared with richer countries.

AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation

The development has been covered in various media outlets as primarily related to the known “adverse events”, namely the small risk of blood clots. However, other factors are far more likely to be driving this decision...

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.